
This work is about a disruptive finding that reveals the fundamental shortcomings of the prospective potential of any would be artificial generative intelligence (AGI), that otherwise could possibly make human intelligence and ingenuity irrelevant, and place humans at the perilous state of servitude: The finding draws upon the main difference between the schemes of knowledge generation of the physical AI systems, and those of Human’s biophysical system: while both embed the existing knowledge and operate computationally on unknown principles, the former meets the end by means of simplified iterative statistical functional models of the brain, that relies on back propagation process solution method, a mechanism totally unrealistic for the brain [Physics Today; December 2024, volume 77, Number 12, Pp 12-16]; and the latter achieves the goal, along with other human characteristics, through the dynamics of vastly complex biochemical phenomenon, possibly involving microscopic effects. The human brain has evolved in response to the timely imperative for survival, adapting to the dynamics of the internal and external environment. This evolutionary journey, marked by transformative breakthroughs, began with early trial-and-error learning and has continued through the development of complex brain neural patterns, guided by genetic processes. The process of adaptation (learning) involves brain engagement with complexities that demand resolution, generally interferes with the normal operations of the brain, particularly those of the neural patterns that regulate the “Endocrine system.” As a result, depending on the intensity of the brain engagement, the human biological system naturally suffers varying degrees of imbalance, specifically affecting body homeostasis. The immediate result would be the sensations of “unease,” commonly referred to as “Stress.” The role of the stress system is well-established across the medical and cognitive sciences. Evolved for adaptation, resilience, and the maintenance of health, the system is defined as a composite, multidimensional construct. It involves the appraisal and processing of a stimulus—the stressor—and the subsequent output, known as the stress response. Within this framework, a stressor is defined as any environmental change that disturbs homeostasis (Schumann, G. et al., 2014, The ADAPT model: from epidemiology to the mechanisms of adolescent mental health. Development and Psychopathology, 26, 1347- 1364). Heavy engagement of the brain in problem resolution, typical in scientific research, involves long periods of ‘over-clocking’ the stress system, involving the SAM and HPA axes and Feedback Mechanism. This creates a high allostatic state (McEwen, B. S. 1998, Protective and damaging effects of stress mediators. New England Journal of Medicine), which the body may interpret as a state of physical danger, triggering the immune system (directly and indirectly) for intensive processes of repair, restoration and coping. Restoring the normal operations of the brain regardless (preventing health impact by default), is the innate response of human biologic system. It is this process of “Stress relief,” that renders formation of proper neural patterns (harmonious with others; in the sense of the ‘Attractors’ in Hopfield Network, which is “problem resolution.” This biophysical process of “Stress development” and “Stress relief” unprocurable in any physical system, has been behind the “resolutions” of seemingly insurmountable complexities of the path of evolutionary human adaptations. This complex resolution power, relying on brain’s neural extensiveness and availed structures, insensitive to the kind and nature of the engaged problems, defines the human intelligence. The dynamics of the machinery of human intelligence, which is further explored in this work, makes it impossible for any advanced AI machinery to surpass humanity; humans will remain masters of their own creations. Nonetheless, the advanced AI systems, the very remarkably effective tool they are, will be highly instrumental in much wondrous progression of our civilization.
Background: Neurotoxicity associated with intrathecal antineoplastic drugs represents a significant clinical challenge in neurology. Among the most devastating complications is myelopathy, an infrequent entity with usually irreversible neurological consequences. Objectives: To perform a comprehensive analysis of all reported cases of myelopathy due to intrathecal antineoplastic agents, including conventional and emerging agents, characterizing their clinical and radiological patterns, prognostic factors, and therapeutic options. Design: Systematic review and meta-analysis of cases following the PRISMA methodology adapted for rare case series (1990-2024). Main Results: Of 487 records identified, 67 cases from 3 publications met the inclusion criteria. Methotrexate was the most frequently implicated agent (47.8%), followed by conventional cytarabine (19.4%), pemetrexed (14.9%), liposomal cytarabine (11.9%), and trastuzumab (11.9%). The temporal distribution revealed five distinct patterns. Magnetic resonance imaging (MRI) was quite sensitive, detecting abnormalities in 92.5% of cases. Regarding prognosis, complete neurological recovery was observed in only 16.4% of patients, demonstrating its poor prognosis. Conclusions: Intrathecal antineoplastic myelopathy is a defined nosological entity with distinctive clinical and radiological characteristics that vary depending on the causative agent. Our findings describe the main characteristics and suggest a pathophysiological mechanism based on the time of presentation.
Dementia is a progressive neurodegenerative condition affecting millions globally, with speech and language pathologists (SLPs) playing crucial roles in assessment, intervention, and management. Despite their significance, practicing SLPs frequently report inadequate knowledge and awareness regarding dementia care. This study aimed to investigate the beliefs, knowledge, and contemporary practices of SLPs in dementia management. A web-based survey was administered to 55 speech and language pathologists across India, assessing their demographic characteristics, awareness of diagnostic and screening tools, therapeutic approaches, use of technology, and perceived challenges in practice. Results indicated that 76.4% of respondents were working professionals, with 78.2% holding postgraduate qualifications. Screening tools such as MMSE and MoCA were utilized by over 80% of participants, while the recently developed ICMR Neurocognitive Toolbox remained unknown to 80% of respondents. Majority of participants (60%) employed blended therapeutic approaches combining techniques from different theoretical frameworks. Regarding alternative medicine, 43.6% believed that combined allopathy with speech-language therapy was beneficial for dementia management. Key challenges identified included poor patient motivation, insufficient clinical exposure, and memory-related difficulties in patients. The findings underscore the necessity for enhanced awareness and training programs regarding evidence-based diagnostic tools, contemporary therapeutic approaches, and the emerging role of assistive technologies in dementia care. This research has significant implications for professional development, curriculum planning, and future strategic initiatives in supporting individuals with dementia across diverse healthcare settings.
Introduction: Autism Spectrum Disorder (ASD) is characterized by atypical behavior, language, and social interaction, with a multifactorial etiology involving genetic and environmental factors. Late diagnosis of ASD significantly impacts neurological development, therapeutic management, and the quality of life of individuals and their families. In this context, this study seeks to describe neurological development and its influence on late diagnosis, as well as to identify the difficulties encountered by healthcare professionals in the early detection of ASD and the difficulties faced by families. Objective: To investigate the effects of late diagnosis of ASD on neural development and the management of its difficulties by professionals and families. Methodology: This is an integrative literature review, based on the following steps of the PRISMA protocol: identification of the theme and formulation of the research question; search and selection of scientific articles; data extraction from selected studies/categorization; critical appraisal of the studies included in the integrative review; synthesis of results and presentation of the review. Results: Among the studies in the reviewed sample, prevalent themes were observed. The most frequently addressed themes were "Difficulties that Healthcare Professionals Encounter in the Early Detection of ASD and Family Difficulties" with 21 articles, "Early Identification as an Influence on the Acceptance of the Diagnosis by Families at Later Times" with 9 articles, and "Neural Development and the Influence of Late Diagnosis" with 2 articles. Discussion: Delayed diagnosis not only compromises brain plasticity and executive functions but also exacerbates inclusion challenges, limiting the effectiveness of early interventions and affecting the quality of life of patients and their families. The lack of standardized protocols and the need for longitudinal studies that allow for monitoring this development in the face of different diagnostic and treatment methods are highlighted. Final consideration: The late diagnosis of ASD harms neurological development and family well-being, reinforcing the need for improvements in health actions aimed at accelerating diagnosis, making it urgent to strengthen early intervention policies.
Background: There is still no approved pharmacological therapy for the core symptoms of autism spectrum disorder (ASD). While there is some clinical evidence supporting the use of megavitamin therapy in ASD, its efficacy in older children with established ASD has yet to be studied. The potential adjunctive role of folinic acid, a biologically active folate derivative increasingly implicated in ASD neurodevelopment, has not previously been examined in combination with megavitamin and homeopathic approaches. Case Presentation: A 7-year-old male (34 kg) with grade 2 ASD diagnosed according to DSM-5 criteria presented after minimal functional progress with intensive specialized rehabilitation. His parents continued to be concerned with limited expressive speech, marked social withdrawal, and significant cognitive delay, with a baseline Childhood Autism Rating Scale, Second Edition (CARS-2 ST) score of 31. A 25-session parenteral protocol of B-vitamin megadoses, folinic acid, vitamin C, and the complex homeopathic preparation Coenzyme Compositum was administered over alternating weeks. Following protocol completion, the patient significantly improved across all assessed domains, with the CARS-2 ST score decreasing to 24. Conclusion: These findings extend the evidence base for integrative megavitamin approaches to older children with ASD and suggest a possible adjunctive role for folinic acid. Larger controlled trials are warranted.